Discovery and therapeutic promise of selective androgen receptor modulators
- PMID: 15994457
- PMCID: PMC2072877
- DOI: 10.1124/mi.5.3.7
Discovery and therapeutic promise of selective androgen receptor modulators
Abstract
Androgens are essential for male development and the maintenance of male secondary characteristics, such as bone mass, muscle mass, body composition, and spermatogenesis. The main disadvantages of steroidal androgens are their undesirable physicochemical and pharmacokinetic properties. The recent discovery of nonsteroidal selective androgen receptor modulators (SARMs) provides a promising alternative for testosterone replacement therapies with advantages including oral bioavailability, flexibility of structural modification, androgen receptor specificity, tissue selectivity, and the lack of steroid-related side effects.
Figures



References
-
- Mooradian AD, Morley JE, Korenman SG. Biological actions of androgens. Endocr. Rev. 1987;8:1–28. - PubMed
-
- Hijazi RA, Cunningham GR. Andropause: Is androgen replacement therapy indicated for the aging male? Annu. Rev. Med. 2005;56:117–137. - PubMed
-
- Kamischke A, Nieschlag E. Progress towards hormonal male contraception. Trends Pharmacol. Sci. 2004;25:49–57. An excellent review of hormonal male contraception and its future direction. - PubMed
-
- Vale W, Wiater E, Gray P, Harrison C, Bilezikjian L, Choe S. 2004 Activins and inhibins and their signaling. Ann. N.Y. Acad. Sci. 2004;1038:142–147. - PubMed
-
- McLachlan RI. The endocrine control of spermatogenesis. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 2000;14:345–362. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources